Showing results (571-580 of 607) with videos related to

Sort By:
Pageof 61
Pharmacoeconomics - Open|January 13, 2026
Cost Analysis of Immunoglobulin Maintenance Treatment of Patients with Chronic Inflammatory Demyelinating Polyneuropathy in SpainSofía de Pedro, María Presa, Josep Gamez, et al.
Pharmacoeconomics - Open|January 14, 2026
Cost-Effectiveness of RefluxStop Versus Nissen Fundoplication and Proton Pump Inhibitors for Refractory Gastroesophageal Reflux Disease: A Spanish Healthcare PerspectiveSam Harper, Khanh Ha Bui, Stuart Mealing, et al.
Pharmacoeconomics - Open|December 15, 2025
Cost-Effectiveness of Chimeric Antigen Receptor (CAR) T-Cell Therapy for Blood Cancers: An Updated Systematic ReviewNishma Patel, Suzanne Farid, Manuel Gomes
Pharmacoeconomics - Open|December 11, 2025
Societal Economic Burden of Antibiotic Resistance in Uganda: A Cost of Illness StudyElly Nuwamanya, Jonathan Mayito, Stephen Okoboi, et al.
Pharmacoeconomics - Open|December 4, 2025
Impact of Inhibitor Development on the Cost Effectiveness of Prophylactic Treatment with Recombinant Factor VIII in Previously Untreated Patients with Severe Hemophilia ALi Yang, Jie Peng, Congling Gu, et al.
Pharmacoeconomics - Open|January 3, 2025
Clinical Complications and Healthcare Resource Utilization Associated with Conventional Management of Sickle Cell Disease with Recurrent Vaso-occlusive Crises and Transfusion-Dependent β-Thalassemia in GermanyChuka Udeze, Nanxin Li, Colin Kunzweiler, et al.
Pharmacoeconomics - Open|January 3, 2024
Understanding the Natural History of Chronic Hepatitis D: Proposal of a Model for Cost-Effectiveness StudiesAnkita Kaushik, Geoffrey Dusheiko, Chong Kim, et al.
Pharmacoeconomics - Open|December 15, 2023
The Efficiency of Increased HCV Testing and Treatment Strategies in Spain to Achieve Elimination GoalsJose Luis Calleja, Jaime Espin, Ankita Kaushik, et al.
Pharmacoeconomics - Open|January 18, 2024
Cost-Effectiveness Analysis of Abrocitinib Compared with Other Systemic Treatments for Severe Atopic Dermatitis in SpainRosa María Romero Jiménez, Pedro Herranz Pinto, Minia Campos Domínguez, et al.
Pharmacoeconomics - Open|January 8, 2024
Health State Utilities Associated with False-Positive Cancer Screening ResultsLouis S Matza, Timothy A Howell, Eric T Fung, et al.
Pageof 61